ESAB Corporation ESAB posts 37 YoY Q4 2025 revenue gain falls 18 after narrow EPS miss CREX CreativeReal posts wider than expected Q4 2025 loss even as its shares rise modestly in trading today HERZ Herzfeld posts 96 percent Q3 2025 revenue decline shares rise 161 percent as investors prize steady credit yields GYRE Gyre Therapeutics falls 198 post Q4 2025 results as EPS miss overshadows 102 yearoveryear revenue growth Is American Res AREC stock a viable buying opportunity Strengthens 20260420 What Selective SIGIP is doing to stay ahead Investor Concern 20260511 VKQ Invesco reports 565 yearoveryear Q1 2026 revenue decline shares dip 02 in todays trading SKYX Platforms SKYX Stock Momentum Trade Market Focus 20260422